Posted on February 27, 2011

Hamad Medical Corporation (HMC) hosted the sixth Qatar Neurology Symposium on 25-26 February at Hajar Auditorium, bringing together an outstanding panel of local and international speakers and neurology professionals who presented the latest updates in the field of neurological sciences.

“We are pleased to be able to host eminent international speakers from the UAE, Lebanon, Saudi Arabia, United Kingdom, USA, Italy, Belgium, Switzerland and Spain as well as from Qatar, particularly HMC’s Neurology Department and Weill Cornell University in Qatar (WCMC-Q),” said the chairman of the symposium Dr Boulenouar Mesraoua, senior consultant neurologist at Hamad General Hospital. The speakers provided expert lectures in the field of epilepsy, headache and movement disorders including the diagnosis and management of these disorders.

[[{"type":"media","view_mode":"media_large","fid":"314","attributes":{"class":"media-image alignright size-medium wp-image-2862","typeof":"foaf:Image","style":"","width":"300","height":"194","alt":""}}]]“The organizing and scientific advisory committee has prepared a very exciting program, with interesting, in-depth discussions following the presentations. Besides the scientific program, we have also prepared a social program to entertain the guests and provide them with a unique insight into the best of Qatar,” added Dr Mesraoua and Dr Hassan Al-Hail, co-chairman of the symposium.

The annual neurology symposium has become extremely popular among neurology specialists in the Gulf countries, as healthcare professionals increase focus on research that will improve the diagnosis and treatment of illnesses prevalent in the region.

As other HMC departments, the Neurology Department is involved in some of the latest international research in this field, including a study that aims to develop a sophisticated intensive care unit (ICU) electroencephalography (EEG) monitoring system, which will allow real-time detection of nonconvulsive seizures or nonconvulsive status epilepticus – improving diagnosis and helping ensure timely, appropriate medical treatment for high-risk ICU patients. Funded through the Qatar National Research Fund (QNRF) and conducted in collaboration with WCMC-Q, Johns Hopkins University, the University of Zurich, and Infinite Biomedical Technology (IBT), the research study also aims to fill the gap in epidemiological data regarding nonconvulsive seizures and nonconvulsive status epilepticus in the ICUs of Gulf countries.

Dr Mesraoua further revealed that the Neurology Department has submitted several research proposals to the QNRF this year including research on peculiar treatment of epilepsy in patients in Qatar, migraine and comorbidity in Qatari patients, and antiepileptic drugs and their idiosyncratic

[[{"type":"media","view_mode":"media_large","fid":"315","attributes":{"class":"media-image aligncenter size-medium wp-image-2867","typeof":"foaf:Image","style":"","width":"300","height":"117","alt":""}}]]

Categories: